PharmaBoardroom

USMCA Sets a New Standard for International Trade

Jonathan Kimball of the Association for Accessible Medicines (AAM) in the USA outlines why the signing of the US-Mexico-Canada Agreement (USMCA) in…

Janet Woodcock – Director, Center for Drug Evaluation and…

In an exclusive interview, Janet Woodcock, head of the Center for Drug Evaluation and Research (CDER) at the US Food & Drug Administration (FDA)…

German Pharma News Roundup: February 2020

Some of the top recent stories from Germany, Europe's leading pharma market according to CPhI, including big new investments from Merck and Bayer, the…

Worldwide Demand for Protective Masks Booms Amid Coronavirus…

The 2019 Wuhan coronavirus outbreak has seen a surge in demand for protective masks as publics across the world seek to protect themselves from…

Key Developments in Russian Pharma 2019

The year 2019, which continued the trend of rapid and numerous changes in healthcare regulations in Russia, was rich with expectations, events and…

Coronavirus Poised to Undermine China’s Healthcare Miracle

Eurasia Group's Aditya Bhattacharji examines the unfolding coronavirus outbreak, the prospects for China's political and economic stability, and how…

The US Healthcare Insurance Industry Hits Back

In 2019, several drug companies testified to the US Senate Finance Committee on medicine price hikes with a narrative of discounts given to health…

China Biosimilar Market Snapshot

Biosimilars are a relatively recent development in the pharmaceutical industry, meaning market penetration is still fairly low, even in many developed…